Furthermore, the SUVmax was significantly higher among patients with high PD-L1 expression levels than among those with low PD-L1 expression levels in the NSCLC (p=0.001) and the ADC (p=0.003) groups. This evidence concerns the gene CD274 and non-small cell lung carcinoma.